Evaluation of "Article 51" experimental projects
Our firm is one of the firms referenced by the CNAM and the DREES for theexternal evaluation of projects falling under the "Article 51" scheme, created by the 2018 Social Security Financing Act. The aim of this scheme is to set up experiments that derogate from common law pricing methods to enable the emergence of innovative organizations in the health and medico-social sectors.
The aim of the "Article 51" experiments is to improve patient pathways, healthcare system efficiency and access to care.
Our evaluation will provide decision-support elements for the bodies that will have to decide on the future of the projects. It is based on three main criteria:
- The feasibility and operationality of the system: to what extent do the stakeholders have the capacity to set up and operate the planned system? Can the target population be reached?
- The effectiveness and efficiency of the system: does the experiment improve the quality and relevance of care? Does it provide an effective solution to a healthcare need?
- Reproducibility of the system: to what extent is the experiment capable of giving rise to a systemic model of the supply/organization of care?
We also evaluate "Article 51" systems in three areas: patient service, changes in professional practices and healthcare expenditure.
Our approach
The evaluation approach is structured around three distinct phases:
- co-construction of the evaluation protocol
- interim assessment
- final assessment
The work carried out during the intermediate and final phases varies from project to project, and may include: interviews and workshops with professionals involved in the experiment, on-site observations, online or field surveys, analyses of charges and costs, descriptive analyses of care pathway data...
At each stage of the evaluation, we work closely with the experimentation leaders and the evaluation unit.
